Skip to main content
Top

Tip

Swipe om te navigeren naar een ander hoofdstuk

2006 | OriginalPaper | Hoofdstuk

Zijn er alternatieven voor hormoonsuppletietherapie bij overgangsklachten?

Auteur : dr. H.A.I.M. van Leusden

Gepubliceerd in: Vademecum permanente nascholing huisartsen

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Overgangsverschijnselen ontstaan door verminderde vorming van oestrogenen. Het betreft vasomotorische klachten, menstruatiestoornissen en urogenitale atrofie.
Literatuur
go back to reference Kronenberg F. Hot flashes: epidemiology and physiology. Ann N Y Acad Sci 1990; 592: 52-68. Kronenberg F. Hot flashes: epidemiology and physiology. Ann N Y Acad Sci 1990; 592: 52-68.
go back to reference Tartaryn IV, Lomax P, Bajorek JG, et al. Postmenopausal hot flushes: a disorder of thermoregulation. Maturitas 1980; 2:101-7. Tartaryn IV, Lomax P, Bajorek JG, et al. Postmenopausal hot flushes: a disorder of thermoregulation. Maturitas 1980; 2:101-7.
go back to reference Freedman RR, Krell W. Reduced thermoregulatory null zone in postmenopausal women with hot flashes. Am J Obstet Gynecol 1999; 181: 66-70. Freedman RR, Krell W. Reduced thermoregulatory null zone in postmenopausal women with hot flashes. Am J Obstet Gynecol 1999; 181: 66-70.
go back to reference Leusden HAIM van. The flush revisited. Eur J Obstet Gynecol Reprod Biol 1994; 57: 137-39. Leusden HAIM van. The flush revisited. Eur J Obstet Gynecol Reprod Biol 1994; 57: 137-39.
go back to reference Freedman RR, Dinsay R. Clonidine raises the sweating threshold in symptomatic but not in asymptomatic postmenopausal women. Fertility Sterility 2000; 74: 20-23. Freedman RR, Dinsay R. Clonidine raises the sweating threshold in symptomatic but not in asymptomatic postmenopausal women. Fertility Sterility 2000; 74: 20-23.
go back to reference Stearns V, Ullmer L, Lopez JF, et al. Hot flushes. Lancet 2002; 360: 1851-61. Stearns V, Ullmer L, Lopez JF, et al. Hot flushes. Lancet 2002; 360: 1851-61.
go back to reference Farmacotherapeutisch Kompas 2002. (Loenen AC van, hoofdredacteur). College voor Zorgverzekeringen (CVZ). Farmacotherapeutisch Kompas 2002. (Loenen AC van, hoofdredacteur). College voor Zorgverzekeringen (CVZ).
go back to reference Pandya KJ, Raubertas RF, Flynn PJ, et al. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Study Center Community Clinical Oncology Program study. Ann Intern Med 2000; 132: 788-93. Pandya KJ, Raubertas RF, Flynn PJ, et al. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Study Center Community Clinical Oncology Program study. Ann Intern Med 2000; 132: 788-93.
go back to reference Hammond MG, Hatley L, Talbert LM. A double blind study to evaluate the effect of methyldopa on menopausal vasomotor flushes. J Clin Endocrinol Metab 1984; 58: 1158-60. Hammond MG, Hatley L, Talbert LM. A double blind study to evaluate the effect of methyldopa on menopausal vasomotor flushes. J Clin Endocrinol Metab 1984; 58: 1158-60.
go back to reference Loprinzi CL, Michalak JC, Quella SK, et al. Megestrol acetate for the prevention of hot flushes. N Engl Med 1994; 331: 347-52. Loprinzi CL, Michalak JC, Quella SK, et al. Megestrol acetate for the prevention of hot flushes. N Engl Med 1994; 331: 347-52.
go back to reference Haataja M, Paul R, Gronroos M, et al. Effect of prostaglandin inhibitor and oestrogen on climacterial symptoms and serum free fatty acids. Maturitas 1984; 5: 263-69. Haataja M, Paul R, Gronroos M, et al. Effect of prostaglandin inhibitor and oestrogen on climacterial symptoms and serum free fatty acids. Maturitas 1984; 5: 263-69.
go back to reference Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000; 356: 2059-63. Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000; 356: 2059-63.
go back to reference Loprinzi CL, Sloan JA, Perez EA, et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 2002; 20: 1578-83. Loprinzi CL, Sloan JA, Perez EA, et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 2002; 20: 1578-83.
Metagegevens
Titel
Zijn er alternatieven voor hormoonsuppletietherapie bij overgangsklachten?
Auteur
dr. H.A.I.M. van Leusden
Copyright
2006
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-313-8808-0_590